Jose Lobo
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 5%
- Cancer Research top 10%
- Co-authors
- Neal RosenDavid B. SolitQing YeYuhong SheJudith S. Sebolt–LeopoldChristine A. PratilasAndrea BassoIman Osman
- Topics
- Colorectal Cancer Treatments and Studies (3 papers)PI3K/AKT/mTOR signaling in cancer (2 papers)CAR-T cell therapy research (2 papers)
- Journals
- NatureBiomaterialsCancer Cell
- Partner nations
- United StatesCanadaPortugal
In The Last Decade
Jose Lobo
8 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 1.2k
- Oncology 758
- Pulmonary and Respiratory Medicine 276
- Pathology and Forensic Medicine 236
- Cancer Research 180
Countries citing papers authored by Jose Lobo
This map shows the geographic impact of Jose Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Lobo more than expected).
Fields of papers citing papers by Jose Lobo
This network shows the impact of papers produced by Jose Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Lobo. The network helps show where Jose Lobo may publish in the future.
Co-authorship network of co-authors of Jose Lobo
This figure shows the co-authorship network connecting the top 25 collaborators of Jose Lobo. A scholar is included among the top collaborators of Jose Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Lobo. Jose Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | 9 | |
| 3 | 34 | |
| 4 | 17 | |
| 5 | 48 | |
| 6 | 352 | |
| 7 | BRAF mutation predicts sensitivity to MEK inhibitionbreakdown → | 1013 |
| 8 | 112 |
About Jose Lobo
Jose Lobo is a scholar working on Oncology, Biochemistry and Biotechnology, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (758 citations), Molecular Biology (1.2k citations) and Pathology and Forensic Medicine (236 citations). Jose Lobo has collaborated with scholars based in United States, Canada and Portugal. Frequent co-authors include Neal Rosen, David B. Solit, Qing Ye, Yuhong She, Judith S. Sebolt–Leopold, Christine A. Pratilas, Andrea Basso, Iman Osman, Ayana Sawai and Gad Getz. Their work appears in journals such as Nature, Biomaterials and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.